Acute Myeloid Leukemia Post Cytotoxic Therapy

general

An acute myeloid leukemia arising as a result of the mutagenic effect of chemotherapy agents and/or ionizing radiation. (WHO, 2001)

71

Centers

183

Active Trials

$103M

Cancer Funding

Specific Cancer Types(1)

Top Centers for Acute Myeloid Leukemia Post Cytotoxic Therapy(71)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.9
2
NCI Comprehensive
High-Volume Research Center
70.9
370.9
4
NCI Comprehensive
High-Volume Research Center
70.9
5
NCI Comprehensive
High-Volume Research Center
70.9
6
High-Volume Research Center
70.9
7
NCI Comprehensive
Active Research Program
67.7
8
NCI Comprehensive
Active Research Program
67.7
9
NCI Clinical
Active Research Program
67.7
10
Active Research Program
67.7
11
Active Research Program
67.7
12
NCI Comprehensive
Active Research Program
57.6
13
NCI Comprehensive
Active Research Program
57.6
14
NCI Comprehensive
Active Research Program
57.6
15
NCI Comprehensive
Active Research Program
57.6
16
NCI Comprehensive
Active Research Program
57.6
17
NCI Comprehensive
Active Research Program
57.6
18
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
57.6
19
NCI Comprehensive
Active Research Program
57.6
20
NCI Comprehensive
Active Research Program
57.6
21
Active Research Program
57.6
22
NCI Comprehensive
Active Research Program
57.6
23
Active Research Program
57.6
24
NCI Comprehensive
Active Research Program
57.6
25
NCI Clinical
Active Research Program
57.6
26
NCI Comprehensive
Active Research Program
57.6
27
NCI Comprehensive
Active Research Program
57.6
28
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
57.6
29
NCI Clinical
Active Research Program
57.6
30
NCI Comprehensive
Active Research Program
57.6
31
Active Research Program
57.6
32
Active Research Program
57.6
33
Active Research Program
57.6
34
Active Research Program
57.6
3557.6
36
Active Research Program
57.6
37
Active Research Program
57.6
38
NCI Comprehensive
Active Research Program
43.6
39
NCI Comprehensive
Active Research Program
43.6
40
NCI Comprehensive
Active Research Program
43.6
41
NCI Comprehensive
Active Research Program
43.6
42
NCI Comprehensive
Active Research Program
43.6
43
NCI Clinical
Active Research Program
43.6
44
NCI Comprehensive
Active Research Program
43.6
45
NCI Comprehensive
Active Research Program
43.6
46
NCI Comprehensive
Active Research Program
43.6
47
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
43.6
48
NCI Comprehensive
Active Research Program
43.6
4943.6
50
Active Research Program
43.6
51
Active Research Program
43.6
52
Active Research Program
43.6
53
Active Research Program
43.6
54
Active Research Program
43.6
55
NCI Comprehensive
Contributing Research Center
33.1
56
NCI Comprehensive
Contributing Research Center
33.1
57
NCI Comprehensive
Contributing Research Center
33.1
58
NCI Comprehensive
Contributing Research Center
33.1
59
NCI Comprehensive
Contributing Research Center
33.1
60
NCI Comprehensive
Contributing Research Center
33.1
61
NCI Comprehensive
Contributing Research Center
33.1
62
NCI Comprehensive
Contributing Research Center
33.1
63
NCI Comprehensive
Contributing Research Center
33.1
64
NCI Comprehensive
Contributing Research Center
33.1
65
Contributing Research Center
33.1
66
Contributing Research Center
33.1
67
Contributing Research Center
33.1
68
Contributing Research Center
33.1
69
BC CancerVancouver, BC
Contributing Research Center
33.1
70
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
71

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →